Jim Cramer Gives His Opinion On Tripadvisor And Incyte

by Craig Jones, Benzinga Staff Writer

September 26, 2017 7:34 AM | 22 seconds read | Make a Comment

Jim Cramer said on CNBC's "Mad Money" that Expedia Inc EXPE and Priceline Group Inc PCLN are superior to Tripadvisor Inc TRIP.

The drug complex of Incyte Corporation INCY is still intact, thinks Cramer. He would wait for the stock to drop another 10 percent and then he would buy more.

Market News and Data brought to you by Benzinga APIs

Posted In: CNBC Jim Cramer Media Mad Money

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Jim Cramer Gives His Opinion On Tripadvisor And Incyte